Characteristics of autoantibody pattern in JSLE subgroups at diagnosis
| Subgroup 1 n=31 (35.6%) | Subgroup 2 n=56 (64.4%) | |
| Anti-Sm | 22 (71.0%) | 0 (0.0%) |
| Anti-u1-RNP | 31 (100.0%) | 0 (0.0%) |
| Anti-dsDNA | 23 (74.2%) | 31 (55.4%) |
| Anti-nucleosome | 22 (71.0%) | 27 (48.2%) |
| Anti-ribosomal P protein | 22 (71.0%) | 26 (46.4%) |
| Anti-histone | 21 (67.7%) | 27 (48.2%) |
| Anti-Ro52/SSA | 20 (64.5%) | 14 (25.0%) |
| Anti-Ro60/SSA | 24 (77.4%) | 16 (28.6%) |
| Anti-La/SSB | 7 (22.6%) | 11 (19.6%) |
| Anti-CL IgG | 8 (25.8%) | 3 (5.36%) |
| Anti-CL IgM | 6 (19.4%) | 2 (3.57%) |
| Anti-β2GP1 IgG | 8 (25.8%) | 3 (5.36%) |
CL, cardiolipin; dsDNA, double-stranded DNA; JSLE, juvenile-onset SLE; RNP, ribonucleoprotein; Sm, Smith; SSA, Sjögren’s syndrome antigen A; SSB, Sjögren’s syndrome antigen B; β2GP1, β2 glycoprotein I.